ArticleKidney international reports2023

Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study.

Dana V Rizk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.